ICAM-1 induction in respiratory cells exposed to a replication-deficient recombinant adenovirus in vitro and in vivo

被引:12
作者
Nicolis, E
Tamanini, A
Melotti, P
Rolfini, R
Berton, G
Cassatella, MA
Bout, A
Pavirani, A
Cabrini, G
机构
[1] Azienda Osped Verona, Ctr Fibrosi Cist, I-37126 Verona, Italy
[2] Univ Verona, Inst Gen Pathol, I-37100 Verona, Italy
[3] IntroGene BV, Leiden, Netherlands
[4] Transgene SA, Strasbourg, France
关键词
ICAM-1; adenovirus; gene therapy; cystic fibrosis;
D O I
10.1038/sj.gt.3300558
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Administration of replication-deficient recombinant adenoviruses (Ad) designed as vectors for gene transfer to the airway tract of rats and monkeys has been associated with a dose-dependent inflammatory process a few days after viral exposure. Among the cellular mechanisms possibly involved, we investigated the expression of intercellular adhesion molecule-1 (ICAM-1), which is known to be induced by parainfluenza, adenovirus type 5 and respiratory syncytial viruses in vitro. To test this hypothesis, an Ad type 5-derived replication-deficient recombinant vector carrying the expression cassette for the cystic fibrosis gene (Ad.CFTR) was either incubated with A549 cells (a human-derived lung epithelial cell line) or instilled by bronchoscopic procedures into the airways of Rhesus monkeys. Ad.CFTR induced expression of ICAM-1 in A549 cells and up-regulated with time the basal levels of ICAM-1 mRNA in lung portions of Rhesus monkeys. These observations indicate that E1-E3-deleted replication-deficient adenoviral vectors are capable of inducing adhesion molecules known to play a role in inflammation.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 32 条
[1]   Gene therapy for cystic fibrosis: Steady progress, should do well [J].
Alton, EWFW ;
Geddes, DM .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (02) :257-259
[2]   Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial [J].
Bellon, G ;
MichelCalemard, L ;
Thouvenot, D ;
Jagneaux, V ;
Poitevin, F ;
Malcus, C ;
Accart, N ;
Layani, MP ;
Aymard, M ;
Bernon, H ;
Bienvenu, J ;
Courtney, M ;
Doring, G ;
Gilly, B ;
Gilly, R ;
Lamy, D ;
Levrey, H ;
Morel, Y ;
Paulin, C ;
Perraud, F ;
Rodillon, L ;
Sene, C ;
So, S ;
TouraineMoulin, F ;
Schatz, C ;
Pavirani, A .
HUMAN GENE THERAPY, 1997, 8 (01) :15-25
[3]  
BOUT A, 1994, GENE THER, V1, P385
[4]   ACUTE RESPONSES OF NONHUMAN-PRIMATES TO AIRWAY DELIVERY OF AN ADENOVIRUS VECTOR CONTAINING THE HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CDNA [J].
BRODY, SL ;
METZGER, M ;
DANEL, C ;
ROSENFELD, MA ;
CRYSTAL, RG .
HUMAN GENE THERAPY, 1994, 5 (07) :821-836
[5]   CYSTIC-FIBROSIS - MOLECULAR-BIOLOGY AND THERAPEUTIC IMPLICATIONS [J].
COLLINS, FS .
SCIENCE, 1992, 256 (5058) :774-779
[6]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[7]   ADMINISTRATION OF AN ADENOVIRUS CONTAINING THE HUMAN CFTR CDNA TO THE RESPIRATORY-TRACT OF INDIVIDUALS WITH CYSTIC-FIBROSIS [J].
CRYSTAL, RG ;
MCELVANEY, NG ;
ROSENFELD, MA ;
CHU, CS ;
MASTRANGELI, A ;
HAY, JG ;
BRODY, SL ;
JAFFE, HA ;
EISSA, NT ;
DANEL, C .
NATURE GENETICS, 1994, 8 (01) :42-51
[8]   TRANSFER OF GENES TO HUMANS - EARLY LESSONS AND OBSTACLES TO SUCCESS [J].
CRYSTAL, RG .
SCIENCE, 1995, 270 (5235) :404-410
[9]   EXPRESSION AND CHARACTERIZATION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR [J].
GREGORY, RJ ;
CHENG, SH ;
RICH, DP ;
MARSHALL, J ;
PAUL, S ;
HEHIR, K ;
OSTEDGAARD, L ;
KLINGER, KW ;
WELSH, MJ ;
SMITH, AE .
NATURE, 1990, 347 (6291) :382-386
[10]   GENE-THERAPY FOR CYSTIC-FIBROSIS [J].
JOHNSON, LG .
CHEST, 1995, 107 (02) :S77-S83